Related Experiment Video
Updated: Jun 8, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Risk profile of hypertensive patients]
J Bulas1, M Ilcík, K Kozlíková
1I. interná klinika Lekárskej fakulty UK a FNsP Bratislava, Slovenská republika. jozef.bulas@faneba.cz
Insights
Hypertensive patients often have multiple risk factors (RF), increasing their risk of coronary heart disease. Early detection and management of these factors are crucial for reducing cardiovascular disease risk.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Context:
- Arterial hypertension is a key factor in global cardiovascular risk.
- Cardiovascular risk assessment includes blood pressure, risk factors, and target organ damage.
- Metabolic risk factors influence antihypertensive drug selection.
Purpose:
- To evaluate risk factors and estimate total cardiovascular risk in hypertensive patients.
- To analyze the relationship between risk factors, metabolic syndrome, and ischemic heart disease.
Summary:
- A study of 60 hypertensive patients revealed a high average of 4.1 risk factors per person.
- Ischemic heart disease prevalence increased with a higher number of risk factors.
- Metabolic syndrome was present in 53% of patients, associated with more risk factors.
Impact:
- Highlights the significant burden of multiple risk factors in hypertensive individuals.
- Emphasizes the link between accumulating risk factors and increased coronary heart disease rates.
- Informs antihypertensive therapy by underscoring the need to manage all modifiable risk factors.
Introduction:
Arterial hypertension is an important component of global cardiovascular risk profile of an individual patient. Estimation of global cardiovascular risk besides the blood pressure level incorporates all risk factors (RF), preclinical cardiovascular diseases (hypertension--induced target organ disease--TOD) and associated clinical conditions, and it should influence the therapy and long-term patient management. A group of metabolic risk factors comprizes several modifyable risk factors, detection of which influences the antihypertensive drug selection. The main goal of antihypertensive therapy is to achieve maximum reduction in the long-term total risk of cardiovascular disease, treating all modifyable risk factors in hypertensive patients.
Patients And Methods:
In this work we present the results of group of 60 hypertensive patients examined for different risk factors detection and subsequent total cardiovascular risk estimation.
Results:
The mean number of risk factors per patient was 4,1 (3% of patients had two RF, 22% of patients had three RF, 37% patients had four factors and 38% patients had five RF present). The ischaemic heart disease was found more frequently among hypertensives with higher number of RF. Metabolic syndrom (MS) was present in 53% of patients. Hypertensives with MS have higher rate of RF (4.9 per person) comparing to thouse without MS (3.6 RF per person).
Conclusion:
We found a quite high number of RF per individual hypertensive patient; the serious unfavourable consequence of this finding was the increased rate of coronary heart disease with the increasing number of risk factors found.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension II: Pathophysiology
Hypertension IV: Drug Therapy and Lifestyle Modifications
Factors affecting Blood pressure
Physiological Factors: